11:07 AM EDT, 10/16/2024 (MT Newswires) -- Optime Care said Wednesday it has expanded its partnership with Rigel Pharmaceuticals ( RIGL ) to include the commercial distribution of Tavalisse, an oral medicine to help patients manage chronic immune thrombocytopenia.

Optime Care, an AscellaHealth Company, said it also manage commercial distribution of Rigel's Gavreto and Rezlidhia products.

Rigel shares were up about 1.8% in recent trading.

Price: 15.58, Change: +0.27, Percent Change: +1.80